查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1866357

全球下腔静脉滤器市场－2025-2030年预测

Global Vena Cava Filters Market - Forecasts from 2025 to 2030
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计下腔静脉过滤器市场将从 2025 年的 11.74 亿美元成长到 2030 年的 15.42 亿美元，复合年增长率为 5.61%。

由于心血管疾病发病率上升、人口老化以及对微创手术需求的增长，全球下腔静脉滤器市场预计将迎来显着增长。下腔静脉滤器置于上腔静脉或下腔静脉内，透过捕捉血栓来预防肺动脉栓塞，特别适用于无法接受抗凝血治疗的患者。这些滤网分为永久型，满足了深层静脉栓塞症（DVT）治疗的关键需求。儘管市场成长潜力巨大，但高昂的治疗费用仍然是一大障碍，尤其是在发展中地区。

市场驱动因素

心血管疾病激增与微创手术

根据世界卫生组织（世卫组织）的数据，心血管疾病是全球首要死因，每年约夺去1,790万人的生命。如此高的发生率，加上人们越来越倾向于微创手术，推动了对下腔静脉滤器的需求。这些装置对于深层静脉栓塞症（DVT）患者至关重要，而DVT约占肺动脉栓塞的90%。医学影像技术的进步，例如数位化导管实验室，正在提高手术的精准度，并促进其进一步普及。预计到2030年，患者对这些技术的认知度不断提高将推动需求成长，并支持市场发展。

人口老化加剧

根据联合国估计，到2050年，全球老年人口预计将翻一番，达到15亿，这将是市场扩张的主要驱动力。老年人更容易患心血管疾病和深层静脉栓塞症（DVT），这增加了对用于预防肺动脉栓塞的下腔静脉滤器的需求。这种人口结构变化，加上久坐等生活方式相关因素，正在增加血管疾病的发生率，并促进这些设备在临床应用中的普及。

优惠的报销政策

已开发国家和开发中国家的支持性医疗保险报销政策正在提高下腔静脉滤器的可近性。这些政策减轻了患者的经济负担，促进了滤网的普及，并推动了市场成长。此外，滤网设计和植入系统的技术进步提高了其疗效和安全性，进一步刺激了市场需求。

市场区隔与区域展望

依滤网类型划分，可回收滤网占据主导地位，这类滤器柔韧性好，可在治疗后取出。以介入方式划分，下腔静脉滤器因其在治疗下肢深层静脉栓塞症（DVT）中的重要作用而占据较大市场份额。按地区划分，北美和亚太地区预计将主导市场，这主要得益于心血管疾病的高发生率和人口老化。欧洲市场预计将因下腔静脉滤器的日益普及而成长。

市场限制

高昂的手术费用仍然是一大挑战，尤其是在开发中国家，这可能会限製手术的可及性并阻碍市场成长。这种经济障碍可能会使患者不愿意选择下腔静脉滤器植入术，影响整体需求。

竞争格局

ALN International, Inc.、Argon Medical Devices、B. Braun Medical, Inc.、Contego Medical, Inc.、Medtronic, Inc.、Johnson & Johnson、Boston Scientific Corporation、Cook Medical、Cordis 主要企业、Bard Peripheral Vascular, Inc. 和 Straub Medical AG 等领先企业正透过产品发布和战略联盟推动创新。这些努力旨在提高设备的精度和可靠性，以保持竞争优势。

市场展望

受心血管疾病发病率上升、人口老化和技术进步的推动，下腔静脉滤器市场预计到2030年将保持强劲成长。北美和亚太地区主导，欧洲的普及速度也正在加速。相关人员需要透过创新且经济高效的解决方案来消除成本障碍，从而最大限度地发挥市场潜力并确保更广泛的应用。

本报告的主要优势：

  • 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
  • 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
  • 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
  • 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
  • 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及其影响、新产品开发、竞争影响

分析范围

  • 历史资料（2022-2024 年）和预测资料（2025-2030 年）
  • 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
  • 竞争对手定位、策略和市场占有率分析
  • 按业务板块和地区（国家）分類的收入成长和预测分析
  • 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

  • 市场概览
  • 市场定义
  • 分析范围
  • 市场区隔

第三章 商业情境

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 波特五力分析
  • 产业价值链分析
  • 政策和法规
  • 策略建议

第四章 技术展望

5. 全球下腔静脉滤器市场（按类型划分）

  • 介绍
  • 上腔静脉滤器
  • 下腔静脉滤器

6. 全球下腔静脉滤网市场（依产品类型划分）

  • 介绍
  • 永久型过滤器
  • 可回收过滤器

7. 全球下腔静脉滤器市场（依最终用户划分）

  • 介绍
  • 医院
  • 门诊手术中心
  • 其他的

8. 全球下腔静脉滤网市场（依地区划分）

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 其他的
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 印尼
    • 泰国
    • 台湾
    • 其他的

第九章 竞争格局与分析

  • 主要企业和策略分析
  • 市占率分析
  • 企业合併、协议、商业合作
  • 竞争对手仪錶板

第十章：公司简介

  • Argon Medical Devices
  • B. Braun
  • Boston Scientific Corporation
  • Cook Medical
  • Cordis Corporation
  • Becton Dickinson
  • ALN Implants Chirurgicaux
  • Mermaid Medical A/S
  • Lifetech Scientific Corporation
  • Integer Holdings Corporation

第十一章附录

  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要收益
  • 分析方法
  • 简称
简介目录
Product Code: KSI061611202

The Vena Cava Filters Market is anticipated to expand from USD 1.174 billion in 2025 to USD 1.542 billion in 2030, with a 5.61% CAGR.

The global vena cava filters market is set for significant growth, driven by the rising prevalence of cardiovascular diseases, an aging population, and increasing demand for minimally invasive procedures. Vena cava filters, deployed via the superior or inferior vena cava, prevent pulmonary embolism by capturing blood clots, particularly for patients unable to use anticoagulation therapies. Available as permanent or retrievable, these filters address critical needs in managing deep venous thrombosis (DVT). Despite growth prospects, high treatment costs pose a barrier, particularly in developing regions.

Market Drivers

Surge in Cardiovascular Diseases and Minimally Invasive Surgeries

Cardiovascular diseases, the leading global cause of death, claim approximately 17.9 million lives annually, according to the World Health Organization. This high prevalence, coupled with a growing preference for minimally invasive interventions, drives demand for vena cava filters. These devices are critical for patients with DVT, which accounts for about 90% of pulmonary embolisms. Advancements in medical imaging, such as digital catheterization laboratories, enhance procedural precision, further boosting adoption. Increasing patient awareness of these techniques is expected to amplify demand, supporting market growth through 2030.

Growing Geriatric Population

The global geriatric population, projected by the United Nations to double to 1.5 billion by 2050, significantly fuels market expansion. Older individuals are more susceptible to cardiovascular conditions and DVT, increasing the need for vena cava filters to prevent pulmonary embolism. This demographic shift, combined with lifestyle-related conditions like sedentary behavior, heightens the incidence of vascular issues, driving the adoption of these devices in clinical settings.

Favorable Reimbursement Policies

Supportive reimbursement frameworks in developed and developing countries are enhancing the accessibility of vena cava filters. These policies reduce financial burdens for patients, encouraging adoption and contributing to market growth. Additionally, technological advancements in filter design and deployment systems are improving efficacy and safety, further propelling market demand.

Market Segments and Geographical Outlook

By filter type, retrievable filters dominate due to their flexibility, allowing removal post-treatment. By intervention type, inferior vena cava filters hold a significant share, driven by their critical role in addressing lower limb DVTs. Geographically, North America and Asia-Pacific regions are expected to lead, fueled by high cardiovascular disease prevalence and aging populations. Europe's market share is projected to grow due to increasing adoption of inferior vena cava filters.

Market Restraints

High procedure costs remain a significant challenge, particularly in developing countries, limiting accessibility and potentially constraining market growth. This affordability barrier may deter patients from opting for vena cava filter treatments, impacting overall demand.

Competitive Landscape

Key players, including ALN International, Inc., Argon Medical Devices, B. Braun Medical, Inc., Contego Medical, Inc., Medtronic, Inc., Johnson & Johnson, Boston Scientific Corporation, Cook Medical, Cordis Corporation, Bard Peripheral Vascular, Inc., and Straub Medical AG, drive innovation through product launches and strategic partnerships. These efforts focus on enhancing device precision and reliability to maintain competitive edges.

Market Outlook

The vena cava filters market is poised for robust growth through 2030, driven by rising cardiovascular disease incidence, an aging population, and technological advancements. While North America and Asia-Pacific lead, Europe's adoption is accelerating. Stakeholders must address cost barriers through innovative, cost-effective solutions to maximize market potential and ensure broader accessibility.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Market Segmentation:

By Type

  • Superior Vena Cava Filters
  • Inferior Vena Cava Filters

By Product Type

  • Permanent Filter
  • Retrievable Filter

By End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL VENA CAVA FILTERS MARKET BY TYPE

  • 5.1. Introduction
  • 5.2. Superior Vena Cava Filters
  • 5.3. Inferior Vena Cava Filters

6. GLOBAL VENA CAVA FILTERS MARKET BY PRODUCT TYPE

  • 6.1. Introduction
  • 6.2. Permanent Filter
  • 6.3. Retrievable Filter

7. GLOBAL VENA CAVA FILTERS MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Others

8. GLOBAL VENA CAVA FILTERS MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. USA
    • 8.2.2. Canada
    • 8.2.3. Mexico
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
    • 8.3.3. Others
  • 8.4. Europe
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. United Kingdom
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. Israel
    • 8.5.4. Others
  • 8.6. Asia Pacific
    • 8.6.1. China
    • 8.6.2. India
    • 8.6.3. Japan
    • 8.6.4. South Korea
    • 8.6.5. Indonesia
    • 8.6.6. Thailand
    • 8.6.7. Taiwan
    • 8.6.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Argon Medical Devices
  • 10.2. B. Braun
  • 10.3. Boston Scientific Corporation
  • 10.4. Cook Medical
  • 10.5. Cordis Corporation
  • 10.6. Becton Dickinson
  • 10.7. ALN Implants Chirurgicaux
  • 10.8. Mermaid Medical A/S
  • 10.9. Lifetech Scientific Corporation
  • 10.10. Integer Holdings Corporation

11. APPENDIX

  • 11.1. Currency
  • 11.2. Assumptions
  • 11.3. Base and Forecast Years Timeline
  • 11.4. Key benefits for the stakeholders
  • 11.5. Research Methodology
  • 11.6. Abbreviations